Percent of patients presenting asthma or COPD who received albuterol

Result area:	1
Objective:	1-4
Strategy:	1-4-1
This measure:		Percent of patients presenting asthma or COPD who received albuterol

On track

99.89 percent

Year to date goal:
At least 95 percent

Albuterol is important in the treatment of bronchospasm.

Albuterol is a beta agonist medication. Bronchospasm: a sudden constriction of the muscles in the walls of the bronchioles.

No measures

Q1	Q2	Q3	Q4
100 percent	99.77 percent

ResultsNOLA